Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
306
NCT00947843
Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents
Phase: Phase 4
Role: Collaborator
Start: Nov 30, 2013
Completion: Oct 31, 2016